Carbinoxamine Maleate Extended-Release Oral Suspension

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 62542-101
  • Package NDC 62542-101-05
  • Application number NDA022556
  • SPL ID 4cdb19d3-49f4-c257-e063-6294a90aaabd
  • SPL set ID 199f46e5-6288-5627-e063-6294a90ae086
  • UNII 02O55696WH
  • RxCUI 1374770

What the source publishes

Labeler
Neos Therapeutics, LP
Active ingredients
Carbinoxamine Maleate
Form
SUSPENSION, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA AUTHORIZED GENERIC
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:62542-101_4cdb19d3-49f4-c257-e063-6294a90aaabd
{
  "name": "Carbinoxamine Maleate Extended-Release Oral Suspension",
  "splId": "4cdb19d3-49f4-c257-e063-6294a90aaabd",
  "labels": [
    {
      "setId": "199f46e5-6288-5627-e063-6294a90ae086",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=199f46e5-6288-5627-e063-6294a90ae086",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=199f46e5-6288-5627-e063-6294a90ae086"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Neos Therapeutics, LP",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "480 mL in 1 BOTTLE, PLASTIC (62542-101-05)",
      "package_ndc": "62542-101-05",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240601"
    }
  ],
  "productId": "62542-101_4cdb19d3-49f4-c257-e063-6294a90aaabd",
  "useDomain": "unknown",
  "dosageForm": "SUSPENSION, EXTENDED RELEASE",
  "productNdc": "62542-101",
  "deaSchedule": null,
  "genericName": "Carbinoxamine Maleate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CARBINOXAMINE MALEATE",
      "strength": "4 mg/5mL"
    }
  ],
  "applicationNumber": "NDA022556",
  "marketingCategory": "NDA AUTHORIZED GENERIC",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20240601",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0323594101053"
    ],
    "unii": [
      "02O55696WH"
    ],
    "rxcui": [
      "1374770"
    ],
    "spl_set_id": [
      "199f46e5-6288-5627-e063-6294a90ae086"
    ],
    "manufacturer_name": [
      "Neos Therapeutics, LP"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:62542-101_4cdb19d3-49f4-c257-e063-6294a90aaabd"